miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells

[1]  E. Zaboli,et al.  Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer , 2020, Scientific Reports.

[2]  M. Kanda,et al.  Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines , 2019, In Vivo.

[3]  Yanqin Sun,et al.  MicroRNA-34a suppresses the invasion and migration of colorectal cancer cells by enhancing EGR1 and inhibiting vimentin , 2019, Experimental and therapeutic medicine.

[4]  R. Słotwiński,et al.  MicroRNAs in pancreatic cancer diagnosis and therapy , 2018, Central-European journal of immunology.

[5]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[6]  Robert C. G. Martin,et al.  Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma , 2018, BMC Cancer.

[7]  P. Assumpção,et al.  A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis , 2017, Oncotarget.

[8]  Jeong-Seok Nam,et al.  Roles of Wnt Target Genes in the Journey of Cancer Stem Cells , 2017, International journal of molecular sciences.

[9]  S. Abediankenari,et al.  MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[10]  S. Zeng,et al.  Lauren classification and individualized chemotherapy in gastric cancer , 2016, Oncology letters.

[11]  C. Xiao,et al.  Transfection of microRNA Mimics Should Be Used with Caution , 2015, Front. Genet..

[12]  Wei Liu,et al.  MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells , 2015, Oncology letters.

[13]  Jian-guo Feng,et al.  Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. , 2015, International journal of oncology.

[14]  V. Orian-Rousseau.  CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis , 2015, Front. Immunol..

[15]  Jun Yu,et al.  miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer , 2014, Oncogene.

[16]  T. Pestell,et al.  MicroRNAs and cancer stem cells: the sword and the shield , 2014, Oncogene.

[17]  Xiaowei Hu,et al.  Identification of Aberrantly Expressed miRNAs in Gastric Cancer , 2014, Gastroenterology research and practice.

[18]  Yang Peng,et al.  MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression , 2014, Bioscience reports.

[19]  Y. Nie,et al.  Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. , 2014, World journal of gastroenterology.

[20]  Li-Ming Tang,et al.  MicroRNA-206 suppresses gastric cancer cell growth and metastasis , 2014, Cell & Bioscience.

[21]  M. Salto‐Tellez,et al.  CD44v8-10 is a cancer-specific marker for gastric cancer stem cells. , 2014, Cancer research.

[22]  D. Graham,et al.  Immunotherapy in gastric cancer. , 2014, World journal of gastroenterology.

[23]  Hua Xu,et al.  CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells , 2013, Cancer Cell International.

[24]  Fang Wang,et al.  MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells , 2013, Journal of Cell Science.

[25]  K. Capaccione,et al.  The Notch signaling pathway as a mediator of tumor survival. , 2013, Carcinogenesis.

[26]  Laisheng Li,et al.  MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1 , 2013, Clinical and Experimental Medicine.

[27]  Lifu Wang,et al.  Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells , 2013, Tumor Biology.

[28]  M. Kelliher,et al.  NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro , 2012, Breast Cancer Research.

[29]  Xuan Wang,et al.  Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics. , 2012, World journal of gastroenterology.

[30]  J. Aster,et al.  Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. , 2011, Blood.

[31]  Sik Yoon,et al.  Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research , 2011, Cellular and Molecular Life Sciences.

[32]  K. Kelnar,et al.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.

[33]  K. Kelnar,et al.  The microRNA miR-34 a inhibits prostate cancer stem cells and metastasis by directly repressing CD 44 , 2011 .

[34]  Xia Shan,et al.  miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines , 2010, International journal of cancer.

[35]  W. O'Gorman,et al.  The potential functions of primary microRNAs in target recognition and repression , 2010, The EMBO journal.

[36]  Kai-Fai Lee,et al.  MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. , 2010, Carcinogenesis.

[37]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[38]  Chen Huang,et al.  MicroRNA profiling of human gastric cancer. , 2009, Molecular medicine reports.

[39]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[40]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[41]  Hyeyoung Min,et al.  Pre-miRNA Loop Nucleotides Control the Distinct Activities of mir-181a-1 and mir-181c in Early T Cell Development , 2008, PloS one.

[42]  M. Leverkus.  Faculty Opinions recommendation of Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. , 2008 .

[43]  P. Chambon,et al.  Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling , 2008, Nature.

[44]  Xin Wei Wang,et al.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. , 2007, Cancer research.

[45]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[46]  Toshio Shimizu,et al.  Introduction of Sd(a) carbohydrate antigen in gastrointestinal cancer cells eliminates selectin ligands and inhibits metastasis. , 2005, Cancer research.

[47]  Q. Su,et al.  Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.

[48]  Jing Wu,et al.  Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor , 2005, Cancer biology & therapy.

[49]  Y. Nio,et al.  [Immunotherapy of gastric cancer]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[50]  Yuxiang Huang,et al.  β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma. , 2016, Acta biochimica et biophysica Sinica.

[51]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..